Activities of Angelika WINZIG related to 2022/2131(DEC)
Shadow reports (1)
REPORT on discharge in respect of the implementation of the budget of the Innovative Health Initiative Joint Undertaking (before 30.11.2021 the Innovative Medicines Initiative 2 Joint Undertaking) for the financial year 2021
Amendments (10)
Amendment 1 #
Motion for a resolution
Paragraph 1
Paragraph 1
1. NotWelcomes that, according to the report of the Court of Auditors (the ‘Court’s report’), the accounts of the IHI Joint Undertaking for the year ended in 31 December 2021 present fairly, in all material respects, the financial position of the IHI Joint Undertaking at 31 December 2021, the results of its operations, its cash flows, and the changes in its net assets for the year that ended, in accordance with financial regulation and with accounting rules adopted by the Commission’s accounting officer; notehighlights, moreover, that, according to the Court’s report, the transaction underlying the accounts are legal and regular in all material respects;
Amendment 2 #
Motion for a resolution
Paragraph 1 a (new)
Paragraph 1 a (new)
1 a. Acknowledges that Horizon Europe envisages ambitious goals for the Joint Undertaking, that can only be achieved if effective solutions that address the weaknesses in the internal control systems and prepare for the future challenges arising from increased responsibilities, e.g. in the area of human resources management and planning, are designed and implemented; points out, in this context, that particularly complicated and burdensome calculations and reporting requirements represent a significant risk of error and calls therefore, to explore the possibilities of simplifications wherever possible and compatible with the existing legal framework;
Amendment 4 #
Motion for a resolution
Paragraph 3
Paragraph 3
3. Notes, from the Court’s report,Is concerned that the Joint Undertaking’s achievement of members’ contribution targets is relatively low; notes, however, that this is due to the long project duration required by the nature of the Joint Undertaking’s research in the area of innovative health, and the scale of global consortia implementing projects; notes that the Joint Undertaking still has to pay EUR 84.3 million for ongoing FP7 projects in the coming years;
Amendment 5 #
Motion for a resolution
Paragraph 4
Paragraph 4
4. Notes, therefore,Draws attention to the fact that the increasing number of ongoing projects from multiple MFF programmes being implemented simultaneously presents the risk that administrative resources needed for the efficient management of these funds, may not be sufficient; notes, fromis pleased that the follow-up on the 2020 discharge, that the Joint Undertaking has taken has led to action tos addressing this issue and that the Joint Undertaking will report on details of the process in the Consolidated Annual Activity Report for 2022;
Amendment 6 #
Motion for a resolution
Paragraph 7
Paragraph 7
7. NotUnderlines, that the implementation rate for the Joint Undertaking’s 2021 payment budget available for Horizon 2020 projects was 97%; notes, furthermore, and that the Joint Undertaking had almost no 2021 operational commitment appropriations, given that the regulation for IMI2 required that all commitments be made before the end of 2020, and the IHI regulation only came into force at the end of the year, no calls were launched in 2021;
Amendment 7 #
Motion for a resolution
Paragraph 9
Paragraph 9
9. Notes with appreciation that Joint Undertaking’s projects have generated 275 assets that completed a significant milestone during the project lifecycle (the target was 50); notes that those assets include, amongst others, tools, methodologies, processes, services, training materials; notes that examples of milestones are key clinical trial phases, animal models, prototypes, commercialisation, patents, publications; notes, moreover, that industry participants in many of the Joint undertaking’s projects are making use of new tools and processes generated by the projects, such as animal models, standards, biomarkers, standard operating procedures (SOPs), use of screening platforms, clinical trial networks;
Amendment 8 #
Motion for a resolution
Paragraph 10
Paragraph 10
10. NotesHighlights that, as regards visibility, that the Joint Undertaking continued to demonstrate the EU added value through assertive communication to target audiences with emphasis on the openness, transparency, relevance, and coherence of Joint Undertaking’s activities; notes that it continued to disseminate the project results and success stories by boosting the diversity of their output to include over 100 written articles in different styles as well as short, accessible videos for promotion via social media; notes, and that in addition, that all IMI project factsheets were added to the newly created IHI website, to facilitate their promotion in the future; encourages to share any successful visibility strategies with other Joint Undertakings in order to present their added-value to citizens;
Amendment 12 #
Motion for a resolution
Paragraph 12
Paragraph 12
12. Notes, from the Annual Activity Report,Appreciates that the continuous improvements in the project management workflow and the coordinated effort made by the staff overcame the difficulties linked to the COVID-19 pandemic period, ensuring business continuity and resulting in a considerable 96.04 % of operational budget execution in 2021;
Amendment 15 #
Motion for a resolution
Paragraph 15
Paragraph 15
15. Notes that, given the multi-annual nature of both programmes and individual research projects, the residual error rate calculated on the duration of the programme provides the most meaningful indication of the financial impact of errors; notes and that it takes into account the corrections made by the Joint Undertaking and the fact that the Joint Undertaking extrapolates the systematic findings of the audits, significantly increasing the cleaning effect of audits; notehighlights, moreover, that as the programmes advance, beneficiaries learn from their errors; notes and that drawing from the lessons learned from the audit findings, the Joint Undertaking also works continuously to better inform beneficiaries of any pitfalls to help them report their costs correctly consequently preventing errors;
Amendment 16 #
Motion for a resolution
Paragraph 19
Paragraph 19
19. NotWelcomes, moreover, that regular information on fraud-related risks and on the procedures to be used in case of suspicion of fraud/irregularities was communicated to the whole staff and that attention was given to cross-sectional issues such as risks linked with conflict of interest, delegation of authority, and segregation of duties.